IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.180
+0.020 (0.93%)
At close: Jul 3, 2025, 1:00 PM
2.160
-0.020 (-0.92%)
After-hours: Jul 3, 2025, 4:57 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $7.51 million as of July 3, 2025. Its market cap has decreased by -82.98% in one year.
Market Cap
7.51M
Enterprise Value
-107.58K
1-Year Change
-82.98%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $7.51M, a decrease of -96.00%. That is a compound annual growth rate of -55.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 7.51M | -59.72% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |